Cartalax 20

Pharmaceutical-Grade Cartalax for Research Applications

Brand: Dragon Pharma

Cartalax (AED Peptide) is a synthetic tripeptide composed of the amino acids alanine, glutamic acid, and aspartic acid (Ala-Glu-Asp). It belongs to a class of short peptide bioregulators that have been investigated in laboratory research involving cartilage biology, connective tissue, and cellular physiology.

Peptide Information

Property	Value
Brand	Dragon Pharma
Peptide Name	Cartalax
Peptide Sequence	Ala-Glu-Asp
Molecular Formula	C12H19N3O8
Molecular Weight	333.29 g/mol
Synonyms	AED Peptide, T-31 Peptide, Alanyl-Glutamyl-Aspartic Acid

Molecular Structure and Stability

Cartalax is a low-molecular-weight synthetic tripeptide designed for laboratory investigation. Its compact structure has made it a subject of research into peptide signaling, gene regulation, and cellular communication.

Experimental studies have examined its interactions with chondrocytes, fibroblasts, and other connective tissue cells involved in extracellular matrix maintenance. Research has also explored its relationship with collagen metabolism, cartilage homeostasis, and cellular renewal processes.

The peptide's stability and defined amino acid sequence make it suitable for controlled laboratory studies investigating peptide bioregulators and tissue biology.

Mechanism of Action

Current research suggests that Cartalax may influence multiple biological pathways involved in connective tissue physiology. Experimental investigations have focused on its potential interaction with:

• Cellular signaling pathways
• Gene expression involved in tissue maintenance
• Chondrocyte proliferation
• Extracellular matrix homeostasis
• Collagen metabolism
• Matrix metalloproteinase (MMP) activity
• Cellular apoptosis
• Inflammatory signaling mechanisms

These proposed mechanisms continue to be investigated in preclinical and laboratory settings, and additional research is needed to better understand their biological significance.

Areas of Scientific Research

Cartilage Biology

Research has explored Cartalax's interaction with cartilage tissue, particularly its relationship with chondrocyte function, extracellular matrix regulation, and cartilage homeostasis.

Connective Tissue Research

Laboratory studies have examined its influence on fibroblast activity, collagen-related pathways, and extracellular matrix remodeling involved in connective tissue biology.

Cellular Aging

Experimental models have investigated Cartalax in relation to cellular senescence, gene regulation, apoptosis, and molecular pathways associated with healthy aging research.

Regenerative Biology

Researchers have studied Cartalax in areas involving tissue regeneration, cellular communication, and stem cell biology to better understand peptide-mediated signaling mechanisms.

Additional Research Topics

Published studies have also investigated Cartalax in connection with:

• Cartilage tissue biology
• Connective tissue physiology
• Fibroblast function
• Gene expression
• Cellular proliferation
• Tissue homeostasis
• Regenerative medicine
• Peptide bioregulators

Lyophilized Peptide Technology

Cartalax is supplied as a lyophilized (freeze-dried) peptide. Lyophilization helps preserve peptide integrity and stability during storage by reducing moisture content.

This preparation method is widely used for research peptides because it supports long-term stability prior to reconstitution when stored under appropriate laboratory conditions.

Storage and Handling

Store the lyophilized peptide in accordance with the manufacturer's recommendations. Protect the product from excessive heat, moisture, and direct sunlight, and keep the container tightly sealed when not in use.

For laboratory work, use appropriate handling procedures and suitable storage conditions to help maintain sample integrity.

Quality Assurance

Dragon Pharma manufactures research products with an emphasis on product consistency and standardized production practices. Product identity, composition, and batch consistency are important considerations for research materials used in laboratory environments.

Researchers should always verify product specifications and follow applicable laboratory protocols before use.

Why Choose Dragon Pharma Cartalax?

Dragon Pharma Cartalax provides researchers with a synthetic tripeptide that has been investigated in studies involving cartilage biology, connective tissue, extracellular matrix regulation, and cellular aging.

Key features include:

• Brand: Dragon Pharma
• Synthetic tripeptide (Ala-Glu-Asp)
• Lyophilized peptide format
• Defined peptide sequence
• Suitable for laboratory and preclinical research
• Investigated in cartilage, connective tissue, and regenerative biology studies

Scientific References

Cartalax (AED peptide) has been described in peer-reviewed scientific literature investigating topics such as cartilage biology, extracellular matrix regulation, fibroblast function, cellular aging, stem cell biology, regenerative medicine, and peptide bioregulators. Readers interested in the underlying evidence should consult the cited publications for detailed methodology and study findings.

Scientific References

1. Linkova N, Drobintseva A, Orlova O, et al. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bulletin of Experimental Biology and Medicine. 2016. DOI: https://doi.org/10.1007/s10517-016-3370-x
2. Khavinson V, Linkova N, Diatlova A, et al. Short Peptides: Regulation of Skin Function During Aging. Advances in Gerontology. 2020. PubMed: https://pubmed.ncbi.nlm.nih.gov/32362083/
3. Khavinson VK, Tarnovskaia SI, Linkova NS, et al. The Influence of Peptides on the Morphofunctional State of Kidneys in Old Rats. Advances in Gerontology. 2014. PubMed: https://pubmed.ncbi.nlm.nih.gov/25946838/
4. Chalisova NI, Linkova NS, Nichik TE, et al. Peptide Regulation of Cell Renewal Processes in Kidney Tissue Cultures from Young and Old Animals. Bulletin of Experimental Biology and Medicine. 2015. DOI: https://doi.org/10.1007/s10517-015-2906-9
5. Ashapkin V, Khavinson V, Shilovsky G, et al. Gene Expression in Human Mesenchymal Stem Cell Aging Cultures: Modulation by Short Peptides. Molecular Biology Reports. 2020. DOI: https://doi.org/10.1007/s11033-020-05506-3
6. Caputi S, Trubiani O, Sinjari B, et al. Effect of Short Peptides on Neuronal Differentiation of Stem Cells. International Journal of Immunopathology and Pharmacology. 2019. DOI: https://doi.org/10.1177/2058738419828613
7. Myakisheva S, Linkova N, Polyakova V, Ryzhak G. Peptides of Cartilage Tissue: Regulation of Chondrocyte Proliferation, Geroprotection and Prospects for Use in Osteoarthrosis. Vrach. 2023. DOI: https://doi.org/10.29296/25877305-2023-10-08